Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Guoyu Huang, Guanbao Zhu Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, People’s Republic of China Abstract: Several members of the sirtuin (SIRT) family, a highly conserved family of NAD+-dependent enzymes, have been shown to...
Main Authors: | Huang G, Zhu G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/sirtuin-4-sirt4-a-therapeutic-target-with-oncogenic-and-tumor-suppress-peer-reviewed-article-OTT |
Similar Items
-
Impact of Short-Term Hypoxia on Sirtuins as Regulatory Elements in HUVECs
by: Simone Johanna Pecher, et al.
Published: (2020-08-01) -
Sirtuins and SIRT6 in Carcinogenesis and in Diet
by: Maria de Céu Teixeira, et al.
Published: (2019-10-01) -
Mitochondrial Sirtuins in Reproduction
by: Giovanna Di Emidio, et al.
Published: (2021-06-01) -
SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
by: Huihuan Wang, et al.
Published: (2021-07-01) -
Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage
by: Wang Y, et al.
Published: (2018-11-01)